Neurocognitive Dysfunction: Clinical Trials

42 trials for Neurocognitive Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 8 recruiting, 5 unknown, 3 active not recruiting. 17 Not applicable, 4 Phase 2, 2 Phase 4, 1 Early Phase 1, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 10, Recruiting 4, Active not recruiting 1, Unknown 1, Withdrawn 1
Phase 24Withdrawn 2, Completed 1, Recruiting 1
Phase 42Terminated 1, Unknown 1
Early Phase 11Completed 1
Phase 11Withdrawn 1
Phase 31Recruiting 1

Follow Neurocognitive Dysfunction: new trials by email Literature Review of Neurocognitive Dysfunction trials Research Report on Neurocognitive Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function
HSCT, Pediatric Cancer
Not yet recruitingCopenhagen University Hospital, Rigshospitalet1002026-02-152026-02-20
Monitoring Neurocognitive Dysfunction and the Impact of Metabolism and Physical Capacity After Paediatric HSCT
Stem Cell Transplant, Late Effect
Not yet recruitingCopenhagen University Hospital, Rigshospitalet1752025-09-012025-09-04
Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)
Active tDCS and Cognitive Training Intervention, Sham tDCS and Cognitive Training Intervention - Brain Concussion, Brain Trauma
Not applicableRecruitingUnited States Naval Medical Center, San Diego1602024-07-252025-11-12
Early Severe Illness TrAnslational BioLogy InformaticS in Humans
Phelebotomy, Broncheoalveolar Lavage, Tracheal Aspirate - Sepsis, ARDS
RecruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's10002024-04-262025-10-06
Neuro-cognitive Function 1 Year Post ICU Discharge Among VV ECMO Survivors
VV ECMO - Neurocognitive Dysfunction
CompletedMeir Medical Center102024-03-012025-05-11
Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI
Memantine Oral Tablet - Neurocognitive Dysfunction
Phase 3RecruitingTata Memorial Centre1012024-02-222025-04-09
The DANCEREX Proof-of-Concept Study for Chronic Neurological Disorders
DANCEREX-DTx, Multidimensional dance-based program, Educational Program - Sclerosis, Multiple, Neurocognitive Impairment, Mild
Not applicableRecruitingFondazione Don Carlo Gnocchi ETS1922024-01-312025-01-10
Ca-Mg Butyrate in Gulf War Illness
Cal-Mag Butyrate, Placebo - Gulf War Illness, Chronic Fatigue
Phase 2RecruitingVA Office of Research and Development1202024-01-152026-10-19
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Neuropsychological assesment, Psychosocial functioning and quality of life (questionnaires), Parental psychosocial functioning (questionnaires) - Retinoblastoma, Neurocognitive Dysfunction
Enrolling by invitationAmsterdam University Medical Center2402023-10-262025-12-04
Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome
Hyperbaric oxygen, Sham - Covid19, Neurocognitive Dysfunction
Not applicableRecruitingAssaf-Harofeh Medical Center912023-06-012026-04-21
Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies
EEG Monitoring, Ropivacaine, Ketamine - Postoperative Delirium, Hemodynamic Instability
Not applicableCompletedBeth Israel Deaconess Medical Center702023-02-282025-11-26
Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection
CO2 flushing, Saline flushing - Stroke, Silent Cerebral Infarction
Not applicableUnknownImperial College London1202022-11-142023-10-23
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Emerald Device Monitoring - Alzheimer Disease, Dementia Alzheimers
RecruitingMclean Hospital402022-05-312025-11-06
Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
COVID-19, Critical Illness
UnknownCorporacion Parc Tauli1262021-11-152022-05-05
An 18-year Follow-up Study on OSA in a Population-based Cohort
Epidemiology, Natural History
CompletedChinese University of Hong Kong2022021-10-202025-12-15
Assessing Neurocognition After Cerebrovascular Intervention
Neurocognitive Assessments, Measurements of inflammatory biomarkers, Carotid Artery Stenting - Carotid Artery Diseases, Neurocognitive Dysfunction
Not applicableRecruitingUniversity of California, San Diego202021-07-152025-02-06
Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
Exposure: COVID-19 severity - Covid19, Neurocognitive Dysfunction
UnknownPontificia Universidad Catolica de Chile802021-05-242021-08-31
Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
Covid19, ARDS
UnknownUniversity of Zurich2002021-05-072021-05-11
tDCS and Cognitive Training in Active Duty Service Members With Mild TBI: A Pilot Study
active tDCS and cognitive training intervention, sham tDCS and cognitive training intervention - Brain Concussion, Brain Trauma
Not applicableCompletedUnited States Naval Medical Center, San Diego562021-01-192025-11-12
Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Genome analysis - Cannabis Use, Neurocognitive Dysfunction
CompletedThe University of Hong Kong1102020-11-012026-03-27

Showing 20 of 42. Sign in to see all of them.

Narrower conditions

Cognition Disorders (42)  ·  Cognitive Dysfunction (5)  ·  COVID-19 (4)  ·  Brain Concussion (3)  ·  Critical Illness (3)  ·  Dementia (3)  ·  Psychotic Disorders (3)  ·  Schizophrenia (3)  ·  Alcohol Drinking (2)  ·  Autoimmune Diseases (2)  ·  Brain Injuries (2)  ·  Brain Injuries, Traumatic (2)  ·  Endocrine System Diseases (2)  ·  Inflammation (2)  ·  Memory Disorders (2)

Broader conditions

Mental Disorders (41)  ·  Neurocognitive Disorders (40)  ·  Nervous System Diseases (13)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Pathologic Processes (8)  ·  Respiratory Tract Diseases (8)  ·  Infections (7)  ·  Lung Diseases (6)  ·  RNA Virus Infections (6)  ·  Virus Diseases (6)  ·  Immune System Diseases (5)  ·  Neurobehavioral Manifestations (5)  ·  Neurologic Manifestations (5)

Interventions

Transcranial Direct Current Stimulation (3)  ·  Atorvastatin (1)  ·  Cobicistat (1)  ·  Darunavir (1)  ·  Dexmedetomidine (1)  ·  Emtricitabine (1)  ·  Functional Residual Capacity (1)  ·  Genome-Wide Association Study (1)  ·  Hyperbaric Oxygenation (1)  ·  Ketamine (1)  ·  Maraviroc (1)  ·  Melatonin (1)  ·  Memantine (1)  ·  Minocycline (1)  ·  Propofol (1)

Sponsors

Tri-Service General Hospital (TSGH) (3)  ·  Copenhagen University Hospital, Rigshospitalet (2)  ·  Duke University (2)  ·  Metagenics, Inc. (2)  ·  United States Naval Medical Center, San Diego (2)  ·  University of California, San Diego (2)  ·  Amsterdam University Medical Center (1)  ·  Assaf-Harofeh Medical Center (1)  ·  Beth Israel Deaconess Medical Center (1)  ·  Charite University, Berlin, Germany (1)  ·  Chiang Mai University (1)  ·  Children's Hospital Los Angeles (1)  ·  Chinese University of Hong Kong (1)  ·  Corporacion Parc Tauli (1)  ·  FolktandvĂ„rden Stockholms lĂ€n AB (1)

Countries

United States (17)  ·  Canada (3)  ·  Israel (3)  ·  Taiwan (3)  ·  Denmark (2)  ·  Italy (2)  ·  Chile (1)  ·  China (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  India (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Hsin-An Chang, M.D. (3)  ·  Joseph Lamb, MD (2)  ·  Lars D Hungerford, PhD (2)  ·  Aleks Leligdowicz, MD PhD (1)  ·  Alexander A Khalessi, MD (1)  ·  Annette C. Moll, MD PhD (1)  ·  Arnoldo Riquelme, PhD (1)  ·  Ashraf S Habib, MD (1)  ·  Balachundhar Subramaniam, MD,MPH,FASA (1)  ·  Carolina Mendez, PhD (1)  ·  Ching Ching, Kate Dr. CHAN (1)  ·  Claudia Spies, MD, Prof. (1)  ·  Constanza Caneo, MD (1)  ·  David R Santiago-Dieppa, MD (1)

Results publications

PMID 31362034, PMID 33096356, PMID 34107933, PMID 34539329, PMID 35444514, PMID 36649152, PMID 37026177, PMID 37105705, PMID 37301934, PMID 37906406, PMID 38564243, PMID 39989365, PMID 40144043, PMID 41673604

NIH funding

I01CX002372 (1), K01AA026005 (1), U01AA020797 (1), U01AA026225 (1), U19AI135972 (1)